Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy

By Yang Sen   Yan Hong-Li   Tao Qi-Fei   Yuan Sheng-Xian   Tang Guan-Nan   Yang Yuan   Wang Li-Li   Zhang Yi-Liang   Sun Shu-Han   Zhou Wei-Ping  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 109-116

Springer Publishing Company

Access to resources Recommend Favorite

NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery

By                

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 39-44

Spandidos Publications

Access to resources Recommend Favorite

The insulin-like growth factor-1 and expression of its binding protein3 in chronic hepatitis C and hepatocellular carcinoma

By                

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1337-1345

Spandidos Publications

Access to resources Recommend Favorite

Deleted in liver cancer 1 expression and localization in hepatocellular carcinoma tissue sections

By            

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 785-788

Spandidos Publications

Access to resources Recommend Favorite

Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma

By Khoury Thaer   Chadha Krishdeep   Javle Milind   Donohue Kathleen   LeVea Charles   Iyer Renuka   Okada Haruhiko   Nagase Hiroki   Tan Dongfeng  

International Journal of Gastrointestinal Cancer, Vol. 35, Iss. 3, 2005-06 ,pp. : 171-177

Humana Press, Inc

Access to resources Recommend Favorite